SETDB2 Antikörper (AA 21-120) (Cy7)
Kurzübersicht für SETDB2 Antikörper (AA 21-120) (Cy7) (ABIN891353)
Target
Alle SETDB2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 21-120
- 
                                            Kreuzreaktivität
- Ratte
- 
                                            Homologie
- Human,Mouse,Dog,Cow,Pig,Horse,Rabbit
- 
                                            Aufreinigung
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from human CLLD8/SETDB2
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1 μg/μL
- 
                                            Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 
                                            Haltbarkeit
- 12 months
 
- 
                                            
- 
    - SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
- 
                                            Andere Bezeichnung
- CLLD8
- 
                                            Hintergrund
- 
                        Synonyms: Histone-lysine N-methyltransferase SETDB2, C13orf4, Chromosome 13 open reading frame 4, Chronic lymphocytic leukemia deletion region 8, Chronic lymphocytic leukemia deletion region gene 8, Chronic lymphocytic leukemia deletion region gene 8 protein, Clld8, CLLL8, Gm293, H3-K9-HMTase, Histone H3-K9 methyltransferase, KMT1F, Lysine N-methyltransferase 1F, Probable histone-lysine N-methyltransferase H3 lysine-9 specic, SEB2, SET domain burcated 2, SET domain protein, burcated, 2, SETB2_HUMAN, Setdb2. Background: Histone methyltransferase involved in left-right axis specification in early development and mitosis. Specifically trimethylates 'Lys-9' of histone H3 (H3K9me3). H3K9me3 is a specific tag for epigenetic transcriptional repression that recruits HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Contributes to H3K9me3 in both the interspersed repetitive elements and centromere-associated repeats. Plays a role in chromosome condensation and segregation during mitosis. 
- 
                                            Gen-ID
- 83852
 Target
- 
                    
 
                                     
                                     
                                    